Ascentage pharma appoints dr. veet misra as chief financial officer and eric huang as senior vice president of global corporate development and finance

Rockville, md. and suzhou, china, july 07, 2025 (globe newswire) -- ascentage pharma group international (nasdaq: aapg; hkex: 6855) (“ascentage pharma” or the “company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced the appointments of veet misra, ph.d., as the company's chief financial officer, and mr. eric huang, as senior vice president of global corporate development and finance. both dr. misra and mr. huang will report directly to dajun yang, m.d., ph.d., the company's chairman & chief executive officer.
AAPG Ratings Summary
AAPG Quant Ranking